Health Care·Health Care Distributors·$101.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.07 | N/A | +5.52% |
management commentary, guidance changes, and full analysis available with Pro.
| +5.52% |
Tone: Neutral
Management acknowledged the competitive landscape but expressed commitment to maintaining operational efficiency. They did not provide specific guidance for future quarters.
Management highlighted ongoing challenges in the market.
They emphasized a focus on operational efficiency.
McKesson's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by 1.32%, likely due to the lack of revenue data and no forward guidance. Investors may be cautious given the ongoing market challenges mentioned by management.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERTEX PHARMACEUTICA
Oct 26, 2009